Clinical Trials Directory

Trials / Completed

CompletedNCT00002325

A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common

A Double-Blind, Placebo-Controlled Study of Fluconazole in the Prevention of Active Coccidioidomycosis and Other Systemic Fungal Infections in HIV-Infected Patients Living in the Coccidioidal Endemic Area

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
—
Sponsor
Pfizer · Industry
Sex
All
Age
13 Years
Healthy volunteers
Not accepted

Summary

To compare the efficacy of fluconazole versus placebo in preventing the development of active coccidioidomycosis and other systemic fungal infections among HIV-infected patients with CD4 lymphocyte counts \< 250 cells/mm3 who are living in the coccidioidal endemic area.

Detailed description

Patients are randomized to receive either fluconazole or placebo daily.

Conditions

Interventions

TypeNameDescription
DRUGFluconazole

Timeline

First posted
2001-08-31
Last updated
2005-06-24

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00002325. Inclusion in this directory is not an endorsement.